The groundbreaking approach of the medication represents a significant advance in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide impacts multiple pathways – here glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) – providing improved sugar regulation and possible weight reduc